<unk> (oral) is a MAOI that is FDA approved for the treatment of major depressive disorder.   Common adverse reactions include decreased systolic arterial pressure, orthostatic hypotension, application site reaction, weight loss, greater than of equal to 5% in body weight, diarrhea, indigestion, headache, insomnia, xerostomia.
Selegiline 
Rasagiline
Perhexiline
Fendiline
Bedaquiline fumarate
Valpromide
Deutetrabenazine
Levodopa